Gansu Lanyao Pharmaceutical Co., Ltd.
-
Founded in:
2006-12-22 -
Country:
China -
Address:
No. 1739, Middle Section of Kunlunshan Avenue, Lanzhou New District, Lanzhou City, Gansu Province -
Tax NO.:
916200007948829218 -
Registered Funds:
84.5 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Thiamine chloride |
Vitamin B1 is an important component of coenzymes required for sugar metabolism
More
Vitamin B1 is an important component of coenzymes required for sugar metabolism |
3mg | 59-43-8 | 9 |
| Riboflavin |
Vitamin B2 is an important coenzyme component required for tissue respiration. Nicotinamide is a component of coenzymes I and II, and is necessary for lipid metabolism and oxidation of tissue respiration.
More
Vitamin B2 is an important coenzyme component required for tissue respiration. Nicotinamide is a component of coenzymes I and II, and is necessary for lipid metabolism and oxidation of tissue respiration. |
1.5mg | 83-88-5 | 19 |
| Vitamin B6 |
Vitamin B6 is a cofactor for many enzymes and is involved in the metabolism of amino acids and fats.
More
Vitamin B6 is a cofactor for many enzymes and is involved in the metabolism of amino acids and fats. |
0.2mg | 8059-24-3 | 13 |
| Nicotinamide |
Nicotinamide is a component of coenzymes I and II, essential for lipid metabolism and oxidation of tissue respiration
More
Nicotinamide is a component of coenzymes I and II, essential for lipid metabolism and oxidation of tissue respiration |
10mg | 98-92-0 | 12 |
| Calcium D-Pantothenate |
Calcium pantothenate is a component of coenzyme A and is involved in the metabolism of sugar, fat, and protein.
More
Calcium pantothenate is a component of coenzyme A and is involved in the metabolism of sugar, fat, and protein. |
1mg | 137-08-6 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glibenclamide |
1. Stimulate the pancreatic islet beta cells to secrete insulin, which presupposes that the islet beta cells also have a certain ability to synthesize and secrete insulin. 2. By increasing portal vein insulin levels or acting directly on the liver, inhibiting liver glycogenolysis and gluconeogenesis, the liver produces and outputs less glucose. 3. It may also increase the sensitivity of extrapancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to reduce fasting blood sugar and postprandial blood sugar.
More
1. Stimulate the pancreatic islet beta cells to secrete insulin, which presupposes that the islet beta cells also have a certain ability to synthesize and secrete insulin. 2. By increasing portal vein insulin levels or acting directly on the liver, inhibiting liver glycogenolysis and gluconeogenesis, the liver produces and outputs less glucose. 3. It may also increase the sensitivity of extrapancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to reduce fasting blood sugar and postprandial blood sugar. |
10238-21-8 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin |
This product is a penicillin antibiotic, which has good antibacterial activity against Streptococcus such as Streptococcus pneumoniae and hemolytic Streptococcus, aerobic Gram-positive cocci such as non-penicillinase-producing Staphylococcus and Enterococcus faecalis, aerobic Gram-negative bacteria such as Escherichia coli, Proteus mirabilis, Salmonella, Haemophilus influenzae, Neisseria gonorrhoeae, and Helicobacter pylori. Amoxicillin exerts its bactericidal effect by inhibiting the synthesis of bacterial cell walls, which can quickly dissolve and rupture bacteria into spherical bodies.
More
This product is a penicillin antibiotic, which has good antibacterial activity against Streptococcus such as Streptococcus pneumoniae and hemolytic Streptococcus, aerobic Gram-positive cocci such as non-penicillinase-producing Staphylococcus and Enterococcus faecalis, aerobic Gram-negative bacteria such as Escherichia coli, Proteus mirabilis, Salmonella, Haemophilus influenzae, Neisseria gonorrhoeae, and Helicobacter pylori. Amoxicillin exerts its bactericidal effect by inhibiting the synthesis of bacterial cell walls, which can quickly dissolve and rupture bacteria into spherical bodies. |
26787-78-0 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Aminophylline |
It has a direct relaxant effect on the smooth muscles of the respiratory tract; it increases the intracellular cAMP content by inhibiting phosphodiesterase; its bronchodilator effect is partly due to the release of endogenous adrenaline and norepinephrine; it is a purine receptor blocker and can counteract the contractile effect of adenine and other substances on the respiratory tract; it enhances the contractility of the diaphragm and improves respiratory function; it has a slight dilating effect on the smooth muscles of the coronary arteries, peripheral blood vessels and bile ducts; it slightly increases contractility and has a slight diuretic effect.
More
It has a direct relaxant effect on the smooth muscles of the respiratory tract; it increases the intracellular cAMP content by inhibiting phosphodiesterase; its bronchodilator effect is partly due to the release of endogenous adrenaline and norepinephrine; it is a purine receptor blocker and can counteract the contractile effect of adenine and other substances on the respiratory tract; it enhances the contractility of the diaphragm and improves respiratory function; it has a slight dilating effect on the smooth muscles of the coronary arteries, peripheral blood vessels and bile ducts; it slightly increases contractility and has a slight diuretic effect. |
317-34-0 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piroxicam |
It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes.
More
It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. |
36322-90-4 | 33 |